Evommune, Inc. (EVMN)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-05) · 99.1 · 99.2 | ||
| 10-Q | Q3-2025 | 8-K (2025-12-11) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Condensed Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Condensed Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Liabilities | ||
| Cash, Cash Equivalents, Short-term and Long-term Investments | — |
|
| Commitments and Contingencies | ||
| Common Stock | ||
| Convertible Preferred Stock | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Fair Value Measurements and Fair Value of Financial Instruments | ||
| Fixed Assets, Net | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net Loss Per Share | — |
|
| Organization and Description of The Business | ||
| Pay Vs Performance Disclosure | ||
| Segments | — |
|
| Share-based Compensation | — |
|
| Stock Option Plan | ||
| Strategic Collaborations and License Agreements | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||